Atara Biotherapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
18.88
|
|
Average Rating
|
3.80
|
|
# Strong Buys
|
5
|
|
# Buys
|
1
|
|
# Holds
|
2
|
|
# Sells
|
1
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.78
|
-0.82
|
-0.04
|
-5.13%
|
|
2022-06-30
|
-0.93
|
0.18
|
1.11
|
119.35%
|
|
2022-03-31
|
-0.98
|
-0.87
|
0.11
|
11.22%
|
|
2021-12-31
|
-0.69
|
-0.96
|
-0.27
|
-39.13%
|
|
2021-09-30
|
-0.94
|
-0.90
|
0.04
|
4.26%
|
|
2021-06-30
|
-0.89
|
-0.91
|
-0.02
|
-2.25%
|
|
2021-03-31
|
-0.92
|
-0.86
|
0.06
|
6.52%
|
|
2020-12-31
|
-0.74
|
-0.95
|
-0.21
|
-28.38%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.51
|
|
2021-12-31
|
-3.63
|
|
2020-12-31
|
-4.21
|
|
2019-12-31
|
-5.71
|
|
2018-12-31
|
-5.24
|
|
2017-12-31
|
-3.99
|
|
2016-12-31
|
-2.75
|
|
2015-12-31
|
-2.03
|
|
2014-12-31
|
-0.96
|